Clinical Trial Update: A Study of Serial Magnetic Resonance Cholangiopancreatography (MRCP) Following Morphine-neostigmine and Secretin Provocation in Healthy Volunteers [Phase 4]

View source ↗

Summary

This Phase 4 clinical trial update reports a study of serial MRCP imaging after morphine-neostigmine and secretin provocation in healthy volunteers to explore t…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Sphincter of Oddi Dysfunction

Drugs mentioned

• Morphine (morphine)
• Neostigmine (neostigmine)
• Secretin (secretin)

Snippet

Sponsor: University of Nottingham | Conditions: Sphincter of Oddi Dysfunction | Phase 4 | Status: COMPLETED